CEND-1 Offers Hope in Advanced Pancreatic Cancer

(MedPage Today) -- Chemotherapy combined with the CEND-1 cyclic peptide showed promising efficacy, and was well tolerated as a first-line treatment, for patients with metastatic pancreatic cancer, researchers reported. In a phase I study of 29...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news